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Trained facilitators’ experiences with
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conversations in oncology: an international
focus group study within the ACTION trial
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Abstract
Background: In oncology, Health Care Professionals often experience conducting Advance Care Planning (ACP)
conversations as difficult and are hesitant to start them. A structured approach could help to overcome this. In the
ACTION trial, a Phase III multi-center cluster-randomized clinical trial in six European countries (Belgium, Denmark,
Italy, the Netherlands, Slovenia, United Kingdom), patients with advanced lung or colorectal cancer are invited to
have one or two structured ACP conversations with a trained facilitator. It is unclear how trained facilitators
experience conducting structured ACP conversations. This study aims to understand how facilitators experience
delivering the ACTION Respecting Choices (RC) ACP conversation.
Methods: A qualitative study involving focus groups with RC facilitators. Focus group interviews were recorded,
transcribed, anonymized, translated into English, and thematically analysed, supported by NVivo 11. The
international research team was involved in data analysis from initial coding and discussion towards final themes.
Results: Seven focus groups were conducted, involving 28 of in total 39 trained facilitators, with different
professional backgrounds from all participating countries. Alongside some cultural differences, six themes were
identified. These reflect that most facilitators welcomed the opportunity to participate in the ACTION trial, seeing it
as a means of learning new skills in an important area. The RC script was seen as supportive to ask questions,
including those perceived as difficult to ask, but was also experienced as a barrier to a spontaneous conversation.
Facilitators noticed that most patients were positive about their ACTION RC ACP conversation, which had prompted
them to become aware of their wishes and to share these with others. The facilitators observed that it took
patients substantial effort to have these conversations. In response, facilitators took responsibility for enabling
patients to experience a conversation from which they could benefit. Facilitators emphasized the need for training,
support and advanced communication skills to be able to work with the script.
Conclusions: Facilitators experienced benefits and challenges in conducting scripted ACP conversations. They
mentioned the importance of being skilled and experienced in carrying out ACP conversations in order to be able
to explore the patients’ preferences while staying attuned to patients’ needs.
Trial registration: International Standard Randomised Controlled Trial Number registry 63110516 (ISRCTN63110516)
per 10/3/2014.
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Background
Advance Care Planning (ACP) is a process of conversa-
tions with patients about their values, goals and prefer-
ences for future medical treatment and care and has the
potential to improve the quality of end of life care [1–3].
Previous studies report that, due to a lack of know-
ledge and experience in how to initiate and facilitate
ACP conversations, many health care professionals
(HCPs) have difficulty conducting ACP conversations
[4–10]. The fear of harming the patient’s coping strat-
egies or damaging their professional relationship with
the patient are also important barriers to HCPs initiating
an ACP conversation [4–8, 10]. A structured approach
and delivery by trained facilitators could be strategies to
overcome these barriers, thus facilitating ACP in clinical
practice [11, 12]. Until now, research has focussed on
the patients’ experiences who participated in a struc-
tured ACP conversation [13]. It has not been investi-
gated yet how trained facilitators experience the use of a
structured approach and whether this could, in their
view, resolve some of the reported barriers to carrying
out ACP conversations.
Currently, there are many different approaches to
carrying out ACP in different settings [1]. One of the
most well-known ACP programmes is the Respecting
Choices (RC) ACP programme [14, 15]. Since its initi-
ation in 1993, the RC ACP programme has developed
towards a structured and widely used programme, par-
ticularly in the USA [16–18]. An adapted version of the
RC ACP programme was tested in the ACTION trial
[19]. The ACTION trial was a Phase III multi-centre
cluster-randomised clinical trial carried out in six
European countries (Belgium (BE), Denmark (DK), Italy
(IT), the Netherlands (NL), Slovenia (SI) and the
United Kingdom (UK)) (see Additional file 1). The
ACTION RC ACP intervention involved one or two
scripted conversations between an ACTION RC ACP
trained facilitator, a patient diagnosed with advanced
lung- or colorectal cancer and, if the patient wished, a
person nominated as their personal representative (PR).
Attending the ACTION RC ACP conversation, enabled
the PR to understand the role of PR, to become familiar
with the patient’s views and wishes and encouraged an
open dialogue between the patient and the PR. The fa-
cilitators assisted patients during the ACTION ACP RC
conversations in exploring their understanding of their
illness, reflecting on their goals, values and beliefs, and
to consider their future treatment preferences and deci-
sions. Facilitators also informed patients about the op-
portunity to document their preferences for (future)
medical treatment and care in the so-called My Prefer-
ences form (see Additional file 2) [19].
This paper presents findings from a qualitative study
which was part of the ACTION trial. The study aimed at
exploring the ACTION RC facilitators experiences with
carrying out the structured RC ACP conversations with
patients and their relatives and whether this could over-
come barriers to conduct an ACP conversation.
Method
Research design
To get insight into the ACTION RC ACP facilitators’
experiences, focus groups were undertaken in each of
the participating countries and thematically analysed
[20]. The study is reported following the Consolidated
Criteria for Reporting Qualitative Research (COREQ)
Guidelines [21].
Participants
To become a facilitator in the ACTION study, respon-
dents had to have working experience as a HCP in care
for patients with cancer (e.g. as a nurse, doctor or social
worker) and were willing to deliver the intervention as
part of their job. To participate in the ACTION study,
facilitators had to take a two-day ACTION RC ACP
training, that consisted of role plays, videos demonstrat-
ing RC ACP conversations and homework assignments
(see also Additional file 2). Facilitators were eligible for
participation in the focus group if they had undertaken
an ACTION RC ACP conversation with at least three
patients, to ensure that they had gained some experience
with the delivery of the ACTION RC ACP conversa-
tions. Eligible facilitators were invited by email.
Data collection
In the summer of 2016 we conducted one focus group in
each participating country. Each focus group lasted ap-
proximately 1.5 h, and was carried out in a private room in
the hospital where the facilitators worked. Personal back-
ground information was collected before the start of the
focus group. An aide memoire, consisting of open-ended
questions and a set of prompts for each question, was used
to guide the focus groups. This aide memoire, based on lit-
erature and expert knowledge of the multidisciplinary inter-
national ACTION research team, covered four main topics:
(1) prior experience with conducting ACP conversations,
(2) prior thoughts about the ACTION RC ACP interven-
tion, (3) experiences with the ACTION RC ACP training
and (4) experiences with conducting the ACTION RC ACP
conversations (Table 1). All focus groups were moderated
and observed by one or two male and female qualitative re-
searchers involved in the ACTION trial with a background
either in health science, psychology, psychiatry, anthropol-
ogy or nursing. They ensured that all predefined topics
were discussed and made field notes during the focus
group. Some moderators knew the participants before the
start of the focus group, for example because the moderator
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had also been present at the ACTION RC training. All
focus groups were recorded and transcribed verbatim.
Data analysis
Thematic analysis was based on the stepwise approach
of the Qualitative Analysis Guide of Leuven (QUAGOL)
[20]. This guide was adjusted by the international quali-
tative research team (MZ, MK, AT, FB, GM, GC, KP) to
accommodate the international scope of this study. A
detailed description of the steps taken is visualised in
Fig. 1.
During the first stage, the transcriptions were anon-
ymized, translated into English and uploaded to NVivo
11. In stage two, each member of the international quali-
tative research team wrote a summary of the key story-
lines of all focus group interviews. Based on these
summaries, a preliminary coding framework including a
description of the content of each code was developed
(MZ). The members of the qualitative research team
tested and developed the coding framework by inde-
pendently coding the same focus group transcript. The
team discussed the coded transcripts during several
meetings until arriving at a consensus on definitions and
application of codes and sub codes (Table 2).
The first researcher (MZ) coded all transcripts in the
third stage. To ensure the validity of the coding process,
each transcript was also independently coded by a sec-
ond researcher of the qualitative research team. After
each coded transcript, discrepancies regarding coding
were solved during telephone meetings and the content
of the transcript was discussed. Subsequently, codes
were categorised and themes were identified. This
process was supported by the development of mind
maps (MZ, MK) and validated by the qualitative research
team. Saturation was achieved, meaning that the analysis
of the last two focus group interviews did not uncover
ideas that could not be assigned to already existing
themes [22].
In stage four, all researchers who had attended one of
the focus groups checked and approved the identified
themes.
In the final stage, relevant quotes to illustrate the iden-
tified themes were extracted by MZ and approved by the
qualitative research team.
Ethical consideration
Ethical approval for the ACTION trial, including the
qualitative work package, was obtained from the locally
responsible Research Ethics Committees in all countries
and institutions. Written informed consent was obtained
from all participating facilitators.
Results
Participant demographics
We conducted seven facilitator focus groups in six par-
ticipating countries (for logistic reasons Dutch facilita-
tors were split into two focus groups). Of the 39
facilitators involved in the ACTION trial, 28 participated
in the focus group interviews. One facilitator (SI) had
conducted only one conversation and was erroneously
included (Table 3). Eight of the 11 excluded facilitators
had undertaken less than three ACTION RC ACP con-
versations. The 28 included facilitators had conducted
ACTION RC ACP conversations with six patients on
average, ranging from one to 14 patients.
Most facilitators were female (n = 24), HCPs (n = 22) and
in most cases a nurse (n = 18). Eighteen facilitators had
during their career participated in a palliative care course.
Thirteen of the 22 HCP-facilitators were involved in clinical
care of patients to whom they had delivered the ACTION
RC ACP conversations (Tables 3 and 4). For each citation
below it is indicated whether the facilitator was involved in
the care of the patient or not.
Table 1 Facilitator focus group aide memoire
Main topics Prompts
Understanding of ACP before ACTION What was your experience of ACP before the ACTION trial?
Experience of ACTION and RC ACP intervention What were your initial thoughts about the ACTION RC ACP intervention?
Experience of RC ACP intervention training - How would you assess the training you received about the
ACTION RC ACP intervention and how to discuss this with patients?
- How helpful was the training in enabling you to feel confident about
delivering the ACTION RC ACP intervention?
Experience of delivering the ACTION RC ACP conversations - Can you tell us about your experience of delivering the ACTION
RC ACP intervention?
Was having a standard script helpful/unhelpful?
- How did you feel about the support you received?
- How did patients and Personal representatives respond?
- Will you/have you used the RC approach, or aspects of it,
in your normal practice (outside the ACTION trial)?
- Were there any things you found difficult or challenging?
- Do you think patients found it helpful or distressing?
Abbreviations: RC Respecting Choice, ACP Advance Care Planning
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Fig. 1 Process data analysis
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Themes
From the experiences of facilitators delivering the AC-
TION RC ACP conversations six themes were identified;
(1) A welcomed opportunity, but challenging, (2) Experi-
ences with using the script, (3) Helpful and difficult, (4)
Feeling uncertain and responsible, (5) Learning process,
Table 2 Coding framework
Main codes Subcodes
Prior experiences with ACP
Thoughts about ACTION
Reasons to participate in ACTION
Becoming a facilitator The RC training
Support during the study
Learning by doing
Personal and professional growth
Becoming aware of RC
Cultural issues During the training
During the conversations
Aspects RC Script_positive
Script_helpful questions
Script_negative
Script_difficult questions
Script_lay-out
My preferences form
Preconditions RC Timing
Place of the conversation
Being a facilitator Needed skills
Dual role facilitator
Be involved in the regular care
Not involved in the regular care
Out of their comfort zone
Workload
Uncertainty
Responsibility
Impressions concerning patients Reasons for patients to participate
Investment
Preparation
Difficulties
Patients responses
The fit between RC and the patient
Personal representative Awareness of their role
Influence on the conversation
The value of ACTION RC ACP conversations Opportunity to reflect and talk
Empowerment of patients
Quality of life
Relationship patient-facilitator
Communication patient-PR
Patients undertake actions
Have the time to conduct an ACP conversation
Helpful
Impact on current practice Using the intervention
Managing study and daily practice
ACP in the future Fit RC intervention to patients
Setting
Script
Part of routine job
Risks for the future
Improvements
Implementation of the intervention
Being part of a research The feeling of being watched by the researcher
Wanted to do it right
Patients should benefit from it
Use as an excuse to the questions they ask
Abbreviations: RC Respecting Choice, ACP Advance Care Planning
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and (6) Thoughts about implementation. Below we de-
scribe these themes in detail.
A welcomed opportunity, but challenging
The facilitators’ experiences with ACP, prior to their par-
ticipation in the ACTION trial, were diverse. Four facilita-
tors appeared to be skilled and clinically experienced in a
more comprehensive type of ACP conversations, the so-
called ‘family conversations’. Three facilitators were familiar
with the concept of ACP, but had no clinical experience
with it. However, the majority of facilitators (n = 22) were
involved in clinical practice and were used to discussing
particular aspects of ACP, such as the preferred place of
care, cardiopulmonary resuscitation or palliative sedation.
Most described discussing these topics in an ad hoc and
unstructured manner, usually in response to patient cues
and fine-tuned to the patient’s coping style. When these
topics were discussed, it was usually when the patient had
reached an advanced stage of illness.
Based on clinical experience and previous understand-
ing, many facilitators had a positive disposition towards
ACP. They believed that ACP conversations were a suit-
able answer to the needs they perceived among patients
with advanced cancer.
‘I personally think that it is a very important thing
[ACP] and I am very aware of its importance, working
with our patients. Being able to speak about how to
deal with care and also the end, in essence, of life, is a
fundamental aspect’ (IT, HCP, involved).
In anticipation of their participation in the ACTION
study, most facilitators welcomed the opportunity to be-
come a facilitator. They considered participation in the
ACTION trial to be an opportunity to learn new skills.
They expected that the ACTION trial could contribute
to the normalisation of ACP as a routine part of care
and could support them to discuss difficult topics.
In addition to their positive stance towards becoming
a facilitator, participants also anticipated some chal-
lenges. The majority of the facilitators expected the con-
versations to be difficult. In particular, facilitators
without medical expertise feared being confronted with
medical questions. Others thought that working with a
script would require great changes to their normal ways
of communicating with patients, and as such would be
demanding. Lastly, some facilitators had doubts about
the appropriateness of the ACTION ACP RC conversa-
tions for some of the patients, because the treatment of
lung cancer stage 3a and 3b is often aimed to be
curative.
‘I had this feeling [of wrong timing] in advance, I
thought: then we are going to say to those people
[patients with lung cancer stage 3a and 3b] that we
will give a treatment aimed at cure, and then we come
up with this ACTION study’ (NL, HCP, involved).
Experiences with using the script
In the ACTION trial, facilitators had dedicated time to
schedule ACTION appointments with patients and were
asked to carry out the RC ACP conversations according
to a script. Facilitators who positively valued the scripted
approach mentioned that it enabled them to conduct
ACP in a more structured and comprehensive manner
than they were used to. The script also offered support
in which topics could be addressed in ACP and helped
them to ask questions they perceived to be difficult for
patients to cope with. Some questions of the script were
especially positively valued. For example, the question ‘If
you were having a good day, what would happen on that
Table 3 Facilitators per country
Country Number of trained facilitators
within the ACTION trial
Respondents
n (%)
Reasons to not included The number of respondents involved in the
clinical care for some of the patient’s
n (%)
BE 10 4 (40%) n = 5: performed less than 3 ACTION
RC ACP conversations
n = 1: not able to participate in the
FG
1 (25%)
DK 4 4 (100%) n.a. 3 (75%)
IT 7 4 (57,1%) n = 3: performed less than 3 ACTION
RC ACP conversations
4 (100%)
NL 8 7 (87,5%) n = 1: Logistic reasons (time and
availably)
5 (71,4%)
SI 5 5 (100%) n.a. 0 (0%)
UK 5 4 (87,5%) n = 1: Logistic reasons (time and
availably)
0 (0%)
Total 39 28 (71,8%) 13 (46,4%)
Abbreviations: FG Focus Group, ACTION RC ACP ACTION Respecting Choice Advance Care Planning
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day?’ was experienced as a key topic that revealed a lot
of relevant information about how patients lived and
coped with their illness. Because of this, several facilita-
tors had already started to use their experiences from in-
volvement in the ACTION study in their wider practice.
‘ …and it [the script] is helpful with questions about
hope and… about pushing through, asking for prior
experiences, these are points that the script covers very
well’ (NL, HCP, involved).
Although facilitators evaluated the script as helpful at
times, most also felt frustrated by the structured approach
of the conversation. This was caused by their sense of be-
ing forced to follow the script even when they thought
that topics were not presented in what they believed to be
the right order, or to ask questions that they considered
inappropriate for the category of patients under study,
particularly in relation to patients’ illness process and
well-being. Consequently, facilitators felt they risked los-
ing rapport and becoming less aligned with patients.
‘That heart and mind clash at such a moment’ (NL,
HCP, not involved).
‘The topics are not impossible… but the guide is
impossible’ (DK, no HCP, involved).
In particular, facilitators who were not involved in regu-
lar patient care and, consequently, did not have a prior
Table 4 Facilitator background information
Facilitator n (%) or mean (range)
n = 28
Age 44 years (28 – 58)
Gender
Male 4 (14.3%)
Female 24 (85.7%)
Highest educational qualification
Doctoral or equivalent 4 (14.3%)
Master degree or equivalent 9 (32.1%)
University degree or equivalent 8 (28.6%)
Post-secondary, non-tertiary 6 (17.9%)
Not elsewhere classified; finishing a master degree 1 (3.6%)
Education: palliative care course
Yes 18 (64.3%)
No 10 (35.7%)
Current professional role
Health Care professional 22 (78.6%)
Nurse 8 (28.6%)
Nurse coordinator 1 (3.6%)
Nurse specialist (in training) 9 (32.1%)
Oncologist 1 (3.6%)
Social worker 1 (3.6%)
Clinical psychologist 2 (7.2%)
No Health Care professional 6 (21.4%)
Researcher 3 (10.7%)
Senior consultant 1 (3.6%)
Lead hospital unit 2 (7.2%)
Involvement in the care for ACTION patients
Yes 8 (28.6%)
For some patients 5 (17.9%)
No 15 (53.6%)
Work experience 20.2 years (4 – 36)
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relationship with patients, found that the formality and
structure of the script could hamper creating a trusting
relationship with patients during the ACTION RC ACP
conversation. Facilitators who worked in clinical practice
had already developed their own style of communication
with severely ill patients. Working in accordance with
the script forced them to use different (e.g. more
medically-orientated) language compared to what they
were used to and to ask ACP-related questions they
would not otherwise have asked. This took many facilita-
tors outside their comfort zone. They described it as a
major challenge to balance working with the script and
having a meaningful and sensitive discussion with the
patients and their PRs.
Some variance between the six participating countries
in terms of facilitators’ experiences with specific ques-
tions was encountered. For some facilitators the ques-
tions about hope (‘What do you hope for with your
current medical plan of care?’ followed by ‘If all these
hopes do not come true, what else would you hope for?’)
were difficult to ask because they did not want to dis-
tress patients. The Italian facilitators, in particular, felt
uncomfortable asking what patients would hope in case
the hopes for current medical treatment would not come
true, because, from their perspective, this involved a risk
of taking away the patients’ hope. In contrast, several fa-
cilitators from other countries felt positive about the
questions regarding hope. They mentioned that, al-
though challenging, these questions led to an in-depth
understanding of patients’ ideas and views regarding
their future in relation to the expected course of their
illness.
‘I think it [hope question] sometimes turns out to be
crucial, to get people to open up’ (SI, HCP, not
involved).
Helpful aspects and difficulties with the structured ACP
conversation
When undertaking ACTION RC ACP conversations,
facilitators did not only experience what it was like to
conduct these conversations, but also observed the re-
sponses of the patients and PRs involved in the con-
versations. Facilitators concluded that most patients
were positive about having had an ACTION RC ACP
conversation, which was encouraging to them. Facili-
tators reported that some patients spontaneously
shared their positive feelings subsequent to the con-
versation. Patients told them they appreciated the in-
formation received or were grateful for being given the
opportunity to discuss perspectives and preferences
for future care and treatment they had not thought
about before. One patient for instance, after having
been transferred to a hospice, contacted the facilitator
to say, ‘thank you’. ‘It was where she wanted to be,
thanks to the interview’ (IT, HCP, involved).
Facilitators observed that some questions prompted pa-
tients to think deeply about their wishes. These included
questions about understanding the nature of their illness
and about what, at this point in their lives, constituted a
good day. Others saw value in the ACTION RC ACP con-
versations because they noticed how it created an oppor-
tunity for patients to make decisions about their own care
and encouraged them to share those wishes with their
HCP. Facilitators considered the involvement of PRs in
the ACTION RC ACP conversations as a key benefit. It
provided an opportunity for an open and valuable discus-
sion between the patient and the PR. It could be the first
time that a PR became aware of their role and of the
wishes of the patient. Facilitators often noticed that PRs
experienced a myriad of emotions and a feeling of respon-
sibility, which also became apparent to the patient.
‘…actually, it was still kind of quite challenging,
painful, emotional, to talk through some of those
experiences again and revisit. But, but equally, she
[the mother] wanted to do it for her daughter, and she
did it, but it wasn’t easy for her’ (UK, HCP, not
involved).
‘You saw that they, that was often the very first time
that they had thought about it and were so open
about it and… so I had a couple like that and well, I
found that very rewarding’ (BE, no HCP, not
involved).
While facilitators emphasized the importance of the PR’s
involvement, some reported that this sometimes compli-
cated the ACTION RC ACP conversation due to the
strong influence of the PR. They had to talk to two indi-
viduals with different perspectives and emotions and, as
such, facilitators concluded that the ACTION RC ACP
conversation was an intervention for the PR as well.
Facilitators observed that patients also experienced diffi-
culties with some parts of the ACTION RC ACP conversa-
tions. Some patients found it difficult to express themselves
or to explore what might happen in the future. Other pa-
tients or PRs became emotional. There were also patients
who did not seem to understand some of the questions,
had difficulty making decisions, or expressed being afraid
that they could not change preferences once they were doc-
umented. These observations led facilitators to think that
participation in an ACTION RC ACP conversation re-
quired quite an effort from patients because of the time
invested, the emotional effort involved, and the energy re-
quired in combination with the time and efforts already
needed to undergo their current treatment. Therefore,
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some facilitators thought that having two ACP conversa-
tions on top of patients’ normal care and treatment was too
much. Nevertheless, facilitators felt that being challenged to
openly and honestly discuss all topics at once could be
overwhelming or upsetting for some patients.
‘I get the impression that in part, it is difficult to
understand it [the questions], but I don't know if it is
difficult to understand because it is formulated in a
certain way, or the patient is put in a very
complicated position emotionally.’ (IT, HCP, involved).
Feeling uncertain and responsible
Despite their observation that many patients positively
evaluated the ACTION RC ACP conversation, many fa-
cilitators remained uncertain about whether these con-
versations were the right thing for patients. This feeling
was caused by the discomfort facilitators experienced in
relation to some parts of the script, the observation that
having an ACTION RC ACP conversation was emotion-
ally challenging for both the patient and the PR, and the
time and energy it took from patients who were already
considerably burdened by their treatment, symptoms
and side-effects. In particular, HCPs worried about the
patients’ wellbeing. In light of this uncertainty, facilita-
tors reported an increased sense of responsibility for en-
suring that the patient derived benefits from the
ACTION RC ACP conversation and to safeguard their
well-being and coping strategies in dealing with their ill-
ness. As one facilitator said:
‘Time must have meaning, that’s what you feel. So
there I feel… I always have patients in that phase, but
here I’m more aware of what that conversation is
supposed to mean, it must be productive in some way’
(NL, HCP, not involved).
Feeling responsible led facilitators to check on pa-
tients’ well-being, also after the ACTION RC ACP con-
versation had finished, and whether they needed any
additional support. Facilitators who were not involved in
the regular care of patients missed this opportunity.
“And I think that hard bit is, we’re used to being able
to follow up our patients, and [if] we’re worried and
we’re thinking they are distressed, (we can) see them
again, you know, it’s very easy to pick up the phone.
But, with these patients, you are leaving them
potentially quite vulnerable and I think that’s really
hard, really hard” (UK, HCP, not involved).
Facilitators’ feeling of responsibility made them develop
goals for themselves. These included the need to keep
the patient and the PR emotionally in balance, to safe-
guard the beneficial effects of the ACTION RC ACP
conversations for the patient and to create and maintain
a trusting relationship throughout the conversation. The
need for working with these goals was reinforced, but
made more difficult, by the necessity of following the
study protocol, including the script, which could be felt
as conflicting with the need to respond sensitively to the
perceived needs and preferences of patients.
Learning process
Over time, many facilitators felt better capable of con-
ducting ACP conversations. They referred to this as a
learning process during which they had gained skills and
had grown more confident to conduct the ACTION RC
ACP conversations
‘It gets better in time. You have to put in some effort,
but eventually it gets easier’ (SI, HCP, not involved).
The initial ACTION RC training constituted the foun-
dation of this learning process. All facilitators highlighted
the ACTION RC training as essential to understand and
become familiar with the scripts and to improve their
communication skills. Facilitators mentioned this had
helped them to stay attuned to patients’ needs while per-
forming the ACTION RC ACP conversation according to
the script.
‘I did find it [the training] intensive but, I am really
grateful that we received it, this training’ (BE, HCP,
involved).
In addition to the training, ‘learning by doing’ was also
important. Practising the conversations in conjunction
with ongoing coaching on the job by the research
team, feedback and reflective conversations with col-
league facilitators and members of the research team,
and feedback of patients and PRs was mentioned to be
indispensable.
Reflective conversations, in particular, addressed difficul-
ties that arose during the conversations and the facilitators’
doubts and uncertainties concerning the balance between
the beneficence of the conversation and the – emotional-
efforts that were required from patient and PR. This was
particularly important because of the facilitators’ increased
sense of responsibility for the patients’ coping and well-
being and their eagerness to make the conversations valu-
able for patients.
‘Yes, I still think the feedback moments are the most
important of all, to discuss the difficult cases and find
a solution together and to… learn from each other’
(BE, no HCP, not involved).
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In addition, facilitators felt more comfortable and
confident to continue conducting ACTION RC ACP
conversations when patients positively valued aspects of
the conversation or when the facilitators themselves
identified worthwhile aspects from the patients’ perspec-
tive. In addition, ‘learning by doing’ taught facilitators
the value of certain communication skills such as the
teach-back method (in which patients are asked to re-
peat in their own words what they understood about the
discussed topic). Many facilitators also experienced ben-
efits to their personal and professional development by
performing ACTION ACP RC conversations. For ex-
ample, facilitators became key figures for the patients.
‘I see this as a very good learning experience for myself
as a health care professional. And in a personal sense
as well. To be a facilitator is basically a privilege’ (SI,
HCP, not involved).
Thoughts about implementation
A number of facilitators worried about the use of
scripted conversations in clinical practice. Some facilita-
tors, in particular those from the UK, stressed that the
ACTION RC ACP conversations should not simply be-
come a kind of tick box exercise after being imple-
mented. They emphasised the importance of skilled
communication and underlined the need for advanced
communication skills to deliver ACTION RC ACP con-
versations effectively and safely and the need to practice
in order to become skilled in the art of these conversa-
tions. Refining their skills had enabled them to work
with the script, and concurrently to reflect upon the
non-verbal communication of the patient and the PR:
‘And that’s my worry, I think, is that the risk is with the
guide and the script, that people will just follow it, maybe
not pick up on those cues’ (UK, HCP, not involved).
The question whether HCPs who are already involved
in patient care should also take up the role of facilitator
set the facilitators thinking. Some indicated that it might
be better if facilitators were a part of the medical team
enabling them to be informed about the patients’ situ-
ation and to build on existing relationships.
‘An existing relationship of trust allows them [patients]
to open up about certain subjects and I don't know if
they would do this or how they could do this with a
stranger in an unfamiliar environment’ (IT, HCP,
involved).
In contrast, others felt that it was desirable not to have
prior knowledge of the patient to safeguard the openness
of the conversation, and that not having a pre-existing
relationship also meant that no dilemmas would arise as
a result of their other roles as nurses or doctors.
‘Well you can say, at least you wouldn’t have any
preconceived opinions. No, you don’t have any’ (DK,
HCP, not involved).
Discussion
This study of facilitators delivering an ACP intervention
revealed that the intervention was supportive to conduct
ACP conversations as well as challenging. Facilitators
learned that addressing topics that made patients think
and discuss their current and future situation and pref-
erences often resulted in meaningful moments during
the conversation. In addition, they felt that patients and
PRs often positively evaluated the conversation. Concur-
rently, the use of a scripted approach in a study context
forced them to address topics and to ask questions in a
way that was very different to their usual approach. Fa-
cilitators felt uncomfortable when they felt that this
scripted approach threatened rapport with the patient
and PR and required considerable –emotional– engage-
ment from patients already managing the considerable
demands imposed by serious illness and its treatment.
Driven by some uncertainty about whether these conver-
sations were experienced as beneficial by the patient and
their PRs, facilitators felt responsible for ensuring that
this was the case. Facilitators emphasized this was a mat-
ter of ‘learning by doing’, supported by reflective conver-
sations and coaching on the job.
Previous studies on HCPs’ perspectives about carrying
out ACP conversations show that HCPs fear taking away
the patients’ hope or that, notwithstanding the potential
benefits of ACP, the conversations will leave the patient
in an emotionally unbalanced state [4–8]. Facilitators in
our study also felt the ethical dilemma between benefi-
cence and non-maleficence. To illustrate, HCPs initiated
ACP and promoted the benefits of ACP, but at the same
time they felt a duty not to harm the patient and to pro-
tect potentially vulnerable patients. The findings suggest
three aspects that encouraged facilitators in performing
the conversations.
Firstly, our study revealed that facilitators went
through a learning process during which they noticed
that patients actually responded well to questions that
they had anticipated would prove difficult. In addition,
they learned how to work with the script. These findings
indicate that becoming experienced gave HCPs self-
confidence in conducting ACP conversations and to
asked ACP-related topics they would usually not have
asked to prevent emotional disruption or harming the
patients’ coping strategy.
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Secondly, the participants in this focus group study
mentioned that facilitators need to be highly skilled and
stressed in particular the need for good communication
skills in order to balance working with the script and
remaining attuned to the patient’s needs. This is in line
with earlier studies that described a lack of communica-
tion techniques as a barrier to undertaking ACP conver-
sations [4–9] and that a skilled facilitator might be the
critical link to an effective ACP conversation [23–25]. It
is interesting that despite the variation in the facilitators’
professional roles and background, none considered
themselves to be lacking competence as a facilitator,
though some were more experienced and confident in
conducting the ACTION RC ACP conversations than
others. The combination of the training, ‘learning by
doing’ and reflective conversations (including discussion
of ethical problems) seems critical to becoming a skilled
facilitator. Still, more research is needed, especially from
patients’ perspectives, on whether facilitators need clin-
ical or palliative care skills.
Lastly, facilitators in this focus group study described
that patients appeared to be grateful for the opportunity
to talk about their preferences for future care despite
moments of emotional distress. Based on this, it could
be argued that emotions expressed during an ACP con-
versation are a part of the patients’ process of coping
with illness. Therefore, HCPs need not label expressed
emotions directly as negative and need not consider
these emotions as an expression of burden for the pa-
tient. To be able to respond carefully to the emotions
expressed by patients, facilitators need advanced com-
munications skills [26].
The facilitators thought differently about whether a fa-
cilitator should be involved in regular patient care in
order to perform high quality ACP conversations. Al-
though Briggs (2004) reported that facilitators should
have an understanding of the patient’s disease and its
progression, it is not specified whether they should also
be involved in regular care for the patient [27]. In the
current study, 13 facilitators were involved in the care
for patients with whom they had the ACTION RC ACP
conversation. Some facilitators argued that being able to
build on an existing trusting relationship made them feel
more comfortable in asking ACP-related questions. In
addition, they stressed the possibility of following-up the
patient after the ACP conversation. In contrast, other fa-
cilitators mentioned the importance of having a conver-
sation without any knowledge or preconceptions in
advance, which may open up the opportunity to really
explore the patient’s perspective. Our results showed
pros and cons regarding the involvement of facilitators
in the regular care for patients. The optimal way forward
might also be influenced by the patients’ personal prefer-
ence to know or not know the facilitator. Therefore,
more research is needed to understand in which situ-
ation it is helpful for the conversation to be conducted
by a facilitator who is already involved in the care for pa-
tients or by an independent person.
Strengths and limitations
Some strengths and limitations of this study have to be
taken into account. Firstly, when implementing a new
complex intervention, time and experience are neces-
sary to ensure that it is delivered effectively. Although
on average facilitators in the study had completed ACP
conversations with six patients, this might not have
been sufficient for them to achieve proficiency. Sec-
ondly, this study was undertaken across six countries.
For the purpose of analysis, the focus group transcripts
were translated into English as a common language.
Some information or nuance might have been lost in
translation, which is an issue in all international studies.
However, by using the summaries made by each local
team and by validating the results with the researchers
of each country, we believe that we took sufficient mea-
sures to mitigate these losses. Thirdly, some modera-
tors knew the participants before the start of the focus
group. This could have influenced the level of openness
of the participants. Finally, it should be noted that pa-
tients who were willing to be included in the ACTION
trial might have self-selected as being receptive to, and
ready to discuss, ACP. This might well have influenced
the nature of the RC ACP conversations, thus leading
the facilitators to have evaluated the conversations
more positively.
Conclusion
Facilitators experienced positive aspects of the ACTION
RC ACP conversation as well as challenges. They indicated
the importance of support and training to build confidence
and becoming skilled in delivering ACP conversations. In
particular, support is needed to address difficult topics and
ask confronting questions that proved to be of value for pa-
tients, but which tended, in practice, to be avoided. Facilita-
tors felt that aspects of the conversations were meaningful
to patients and PRs, but also questioned the efforts it took
from patients and PRs.
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